⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482000 | 0.95 | — | — | |
| SCHEMBL13621333 | 0.76 | — | — | |
| SCHEMBL4946891 | 0.76 | — | — | |
| SCHEMBL4946208 | 0.76 | — | — | |
| SCHEMBL3654581 | 0.76 | — | — | |
| SCHEMBL4948167 | 0.76 | — | — | |
| SCHEMBL1092235 | 0.76 | — | — | |
| SCHEMBL4943786 | 0.76 | — | — | |
| SCHEMBL4942419 | 0.76 | — | — | |
| SCHEMBL412622 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1906911-B1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE & TECH ORG (AU) | 2019-09-25 | — | — | EP | disclosed |
| US-9131681-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-09-15 | — | — | US | disclosed |
| US-9017643-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-04-28 | — | — | US | disclosed |
| US-20150004095-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2015-01-01 | — | — | US | disclosed |
| US-20140322326-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| US-8815291-B2 | Particles comprising a releasable dopant therein | Austrailian Nuclear Science & Technology Organisation (AU) | 2014-08-26 | — | — | US | disclosed |
| US-20080199523-A1 | Emulsion with hydrophilic, hydrophobic phase ; reacted in presence of catalyst; anticancer agents, aids, antiarthritic agents, antidiabetic agents, analgesics | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION | 2008-08-21 | — | — | US | disclosed |
| EP-1906911-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2008-04-09 | — | — | EP | disclosed |
| WO-2006133519-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2006-12-21 | — | — | WO | disclosed |
| EP-0420522-B1 | Precured silicone emulsion | DOW CORNING (US) | 1996-05-08 | — | — | EP | disclosed |
| US-5145907-A | Using a divalent tin catalyst to effect crosslinking; shelf life; dry to elastomer films reinforced with colloidal silica | DOW CORNING CORPORATION (US) | 1992-09-08 | — | — | US | disclosed |
| EP-0420522-A2 | Precured silicone emulsion | DOW CORNING CORPORATION (US) | 1991-04-03 | — | — | EP | disclosed |
| US-4954565-A | SHELF-STABLE WHEN CONTAINING COLLOIDAL SILICA FILLER; USING A STANNOUS CARBOXYLATE CURING CATALYST | DOW CORNING CORPORATION (US) | 1990-09-04 | — | — | US | disclosed |